SCHEMBL25958664

SCHEMBL25958664

CCc1c(Br)c(C)nn1C1CCCCO1

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.45
CYP4F2 P78329 2/20 0.34
CYP4A11 Q02928 2/20 0.34
RET P07949 4/20 0.34
CYP2C19 P33261 1/20 0.33
ALDH1A1 P00352 2/20 0.31
POLB P06746 2/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
RXRA P19793 1/20 0.30
RXRB P28702 1/20 0.30
RXRG P48443 1/20 0.30
DRD1 P21728 1/20 0.30
PDE8B O95263 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30758273 0.87 GAA (0.44) GAACYP4F2CYP4A11RETCYP2C19
SCHEMBL29027783 0.84 GAA (0.41) GAACYP4F2CYP4A11RETCYP2C19
SCHEMBL21002088 0.82 GAA (0.49) GAACYP4F2CYP4A11RETCYP2C19
SCHEMBL27329777 0.77 GAA (0.48) GAACYP4F2CYP4A11RETCYP2C19
SCHEMBL30758185 0.77 GAA (0.40) GAACYP2C19ALDH1A1KMT2A
SCHEMBL20488945 0.76 GAA (0.44) GAACYP4F2CYP4A11RETCYP2C19
SCHEMBL31281723 0.76 GAA (0.44) GAACYP4F2CYP4A11RETCYP2C19
SCHEMBL25958665 0.76 GAA (0.39) GAACYP4F2CYP4A11
SCHEMBL19255898 0.76 GAA (0.39) GAACYP4F2CYP4A11
SCHEMBL1475947 0.74 ALDH1A1 (0.43) GAACYP4F2CYP4A11RETCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230250079-A1 SMALL MOLECULE MODULATORS OF IL-17 LEO PHARMA A/S (DK) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230250079-A1 SMALL MOLECULE MODULATORS OF IL-17 IL17A, IL2, IL23R GAA 920/4885CYP4F2 2305/4885CYP4A11 554/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.